Having trouble viewing this email? View in your browser.
ESCMID Logo

16 May 2017
WEEKLY NEWS

Dear colleagues,

We have some interesting profiles of researchers who are looking for a job. Check out ESCMID’s job platform.

ESCMID has a new ECC in Turkey: Clinical Microbiology at Ege University School of Medicine in Izmir.

ESCMID Study Group for Antibiotic Policies (ESGAP) has changed its name to ESCMID Study Group for Antimicrobial stewardshiP.

Your ESCMID communications editors

 

ESGAP publishes paper on reduced access to older antibiotics in CMI

ESCMID’s study group on antibiotic policies ESGAP published a paper on the access to older antibiotics in the journal Clinical Microbiology and Infection. The study showed that antibiotics used to treat a variety of common bacterial infections are becoming more difficult to access, mostly because the drugs are less profitable for manufacturers to produce and market. ESGAP conducted the study with researchers from Action on Antibiotic Resistance (ReAct), the International Society of Chemotherapy, the British Society for Antimicrobial Chemotherapy (BSAC) and the French Infectious Diseases society (SPILF). Have a look at the paper and the press release.

› Read more
 

CMI highlight: Should we screen asymptomatic MSM for urethral gonorrhoea?

Researchers in Australia examined if men who have sex with men (MSM) without urethritis symptoms should be screened for urethral gonorrhoea. They used sensitive nucleic acid amplification testing to assess the rate of asymptomatic urethral gonorrhoea in MSM attending a sexual health centre for sexually transmitted infection screening. The study showed that about one in ten of those with positive urine tests reported no symptoms. The findings support guidelines that recommend screening asymptomatic MSM for urethral gonorrhoea.

› Read more
 

Job opening for professional affairs manager at ESCMID office in Basel

To support the future development of our non-profit society ESCMID is currently seeking applications from qualified candidates for the position of a Professional Affairs Manager (80%) in Basel, Switzerland. The new person will replace Dianne White, who will be leaving the ESCMID office in the summer. We thank Dianne for 15 years of dedicated work for the society.

› Read more
 

You may now apply for an observership at WHO in Copenhagen

On ESCMID’s website you find more information on the objectives and election criteria for the one-week observership at the World Health Organisation’s Regional Office for Europe, Division of Communicable Diseases, Health Security and Environment (DCE). The deadline for applications is 6 June at 12:00 noon CET.

› Read more
 

EMA 2016 annual report focuses on antimicrobial surveillance, vaccine hesitancy

The European Medicines Agency’s (EMA) has published its 2016 annual report. EMA recommended a marketing authorisation for 81 medicines for human use, including 27 new active substances. On the veterinary side, 11 medicines were approved, including six new active substances. One in three of these prevent viral or bacterial infections in food-producing animals. EMA’s report also highlights three main topics in 2016 including vaccine hesitancy and surveillance of antimicrobial consumption.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.